{"id":"tetravalent-influenza-virus-lysis-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This vaccine contains inactivated (killed) influenza virus particles representing four circulating strains (two influenza A subtypes and two influenza B lineages). Upon administration, the viral antigens trigger both humoral (antibody) and cellular immune responses, priming the immune system to recognize and neutralize these influenza strains if encountered naturally. The vaccine aims to reduce infection rates, severity of illness, and complications from seasonal influenza.","oneSentence":"A tetravalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus through viral antigen presentation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:38:18.297Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of seasonal influenza (tetravalent strains)"}]},"trialDetails":[{"nctId":"NCT05107375","phase":"PHASE3","title":"Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine","status":"COMPLETED","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2021-09-03","conditions":"Coronavirus Disease 2019","enrollment":299}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tetravalent influenza virus lysis vaccine","genericName":"Tetravalent influenza virus lysis vaccine","companyName":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","companyId":"anhui-zhifei-longcom-biologic-pharmacy-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"A tetravalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus through viral antigen presentation. Used for Prevention of seasonal influenza (tetravalent strains).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}